[Polycystic ovary syndrome (author's transl)]

Area of Science:

• Endocrinology
• Reproductive Medicine
• Biochemistry

Background:

• Polycystic ovary syndrome (PCOS), also known as Stein-Leventhal syndrome, is a complex endocrine disorder.
• Recent advancements have improved the understanding of PCOS physiopathology, particularly Type I PCOS.

Purpose of the Study:

• To define the biochemical characteristics of Type I PCOS.
• To analyze the mechanisms of hyperandrogenism in PCOS.
• To review the role of estrogen feedback and ovulation induction in PCOS.

Main Methods:

• Biochemical analysis of hormone secretion (LH, FSH) under basal and stimulated conditions (LH-RH test).
• Assessment of estrogen feedback mechanisms at the hypothalamic level.
• Evaluation of androgen production and transformation pathways (androstenedione, testosterone, dihydrotestosterone, androstanediol).
• Clinical observation of ovulation induction with clomiphene administration.

Main Results:

• Type I PCOS is characterized by high, anarchic LH secretion with an exaggerated LH response to LH-releasing hormone (LH-RH).
• Follicle-stimulating hormone (FSH) levels remain normal under basal and stimulated conditions.
• Estrogen feedback mechanisms at the hypothalamus are intact, allowing for ovulation induction with clomiphene in most cases.
• Ovarian hyperproduction of androstenedione and its subsequent conversion to potent androgens contribute to hyperandrogenism.

Conclusions:

• Type I PCOS is biochemically defined by specific patterns of LH and FSH secretion.
• Intact hypothalamic-estrogen feedback supports ovulation induction strategies.
• Understanding androgen synthesis pathways is crucial for managing PCOS-related hyperandrogenism.